SC
YARW

Shay Capital’s Yarrow Bioscience YARW Stock Holding History

Shay Capital’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948K Sell
29,133
-3,072
-10% -$99.6K 0.06% 219
2026
Q1 		$962K Sell
32,205
-282
-0.9% -$8.23K 0.08% 177
2025
Q4 		$942K Buy
32,487
+22,635
+230% +$454K 0.1% 192
2025
Q3 		$165K Buy
+9,852
New +$322K 0.01% 359
2025
Q2 		– Sell
-360
Closed -$28.5K – 438
2025
Q1 		$28.5K Buy
+360
New +$44.3K ﹤0.01% 295

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Shay Capital's YARW Position: Q2 2026 in Review

Shay Capital reduced its Yarrow Bioscience (YARW) stake by 9.5% in Q2 2026, selling an estimated $99.6K and leaving 29,133 shares worth $948K. The position accounts for 0.06% of the portfolio, ranked #219.

Shay Capital first reported a position in YARW in Q1 2025 and has held it in 5 quarters since. The position peaked at $962K in Q1 2026. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Shay Capital held 29,133 shares of Yarrow Bioscience worth $948K as of Q2 2026.
  • Shay Capital sold 3,072 Yarrow Bioscience shares in Q2 2026, an estimated $99.6K.
  • Yarrow Bioscience made up 0.06% of Shay Capital's portfolio in Q2 2026, its #219 holding.
  • Shay Capital first reported a position in Yarrow Bioscience in Q1 2025 and has held it in 5 quarters since.
  • Shay Capital's Yarrow Bioscience position peaked at $962K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.